 |
|
COMMENTS AND OPINIONS
Status Epilepticus in Patients With CNS Metastases—Reply
David Schiff, MD;
Robert Cavaliere, MD
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
We appreciate the comments of Drs Blitshteyn and Jaeckle. We share their perception that the outcome is worse with status epilepticus (whether convulsive or nonconvulsive) from intracranial metastases than with primary brain tumors. Several factors may contribute to this. Patients with brain metastases tend to be older than patients with primary brain tumors, and in fact, the most epileptogenic primary brain tumors tend to be low grade and associated with relatively good survival.1 In our series, patients with brain metastases had more acute illnesses thought to be contributing to status epilepticus than did patients with primary brain tumor. Furthermore, patients with leptomeningeal seeding from cancer appear to be highly represented in case series of cancer with status epilepticus,2-6 and most of these patients have a systemic primary tumor. Finally, brain metastases, particularly leptomeningeal metastases, continue to have a worse overall prognosis than . . . [Full Text of this Article] AUTHOR INFORMATION
RELATED LETTER
Status Epilepticus in Patients With CNS Metastases
Svetlana Blitshteyn and Kurt A. Jaeckle
Arch Neurol. 2007;64(6):916.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Clinical Implications of Status Epilepticus in Patients With Neoplasms
Robert Cavaliere, Elana Farace, and David Schiff
Arch Neurol. 2006;63(12):1746-1749.
ABSTRACT
| FULL TEXT
|
